Novartis AG (1NOVN)
MTA
Closed
Aug 21, 2026
Day's Range
133.4652 wk Range
102.00Overview - 1NOVN - Novartis AG
Key Statistics
Valuation
Enterprise Value
257.45B
P/E (Trailing)
‪24.04‬
PEG Ratio
‪-1.38‬
Price / Sales (TTM)
‪4.57‬
Price / Book
‪7.29‬
EV / EBITDA
‪13.01‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Held by Insiders
‪2.11%‬
Held by Institutions
‪45.89%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪134.61‬
200-Day Avg
‪128.24‬
Dividends
Payout Ratio
‪69.86%‬
Market Cap - 1NOVN - Novartis AG
Peers - 1NOVN - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1NOVNMTANovartis AG238.75BMarket Cap+22.16%52-week change24.02P/E (Trailing)‪22.50%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+44.62%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+35.82%52-week change31.30P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+21.59%52-week change74.43P/E (Trailing)‪9.80%‬Profit Margin
- 1ROMTARoche Holding AG294.63BMarket Cap+26.89%52-week change24.52P/E (Trailing)‪19.60%‬Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+44.15%52-week change125.16P/E (Trailing)‪4.76%‬Profit Margin
- 1AMGNMTAAmgen Inc.155.67BMarket Cap+34.30%52-week change27.31P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - 1NOVN - Novartis AG
About
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
